NOT FOR DISTRIBUTION
Header cover image

Vincent Medical Holdings

Market Cap

HK$1.0b

Last Updated

2021/04/14 10:28 UTC

Data Sources

Company Financials +

Executive Summary

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. More Details


Snowflake Analysis

Outstanding track record, undervalued and pays a dividend.


Similar Companies

Share Price & News

How has Vincent Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1612 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 1612's weekly volatility has decreased from 16% to 8% over the past year.


Market Performance


7 Day Return

1.2%

1612

-0.7%

HK Medical Equipment

-2.5%

HK Market


1 Year Return

91.9%

1612

38.4%

HK Medical Equipment

26.4%

HK Market

Return vs Industry: 1612 exceeded the Hong Kong Medical Equipment industry which returned 38.4% over the past year.

Return vs Market: 1612 exceeded the Hong Kong Market which returned 26.4% over the past year.


Shareholder returns

1612IndustryMarket
7 Day1.2%-0.7%-2.5%
30 Day4.4%6.6%-1.8%
90 Day-23.6%-9.3%0.5%
1 Year94.6%91.9%39.8%38.4%31.2%26.4%
3 Year166.0%150.0%198.8%185.6%6.0%-5.2%
5 Yearn/a280.9%248.2%47.3%22.5%

Long-Term Price Volatility Vs. Market

How volatile is Vincent Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Vincent Medical Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 1612 (HK$1.61) is trading below our estimate of fair value (HK$9.46)

Significantly Below Fair Value: 1612 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 1612 is good value based on its PE Ratio (4.8x) compared to the HK Medical Equipment industry average (28x).

PE vs Market: 1612 is good value based on its PE Ratio (4.8x) compared to the Hong Kong market (11.7x).


Price to Earnings Growth Ratio

PEG Ratio: 1612's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: 1612 is good value based on its PB Ratio (1.7x) compared to the HK Medical Equipment industry average (3x).


Future Growth

How is Vincent Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-11.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1612's earnings are forecast to decline over the next 3 years (-11.1% per year).

Earnings vs Market: 1612's earnings are forecast to decline over the next 3 years (-11.1% per year).

High Growth Earnings: 1612's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 1612's revenue (3.4% per year) is forecast to grow slower than the Hong Kong market (13.3% per year).

High Growth Revenue: 1612's revenue (3.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1612's Return on Equity is forecast to be low in 3 years time (10.5%).


Past Performance

How has Vincent Medical Holdings performed over the past 5 years?

30.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1612 has high quality earnings.

Growing Profit Margin: 1612's current net profit margins (18.8%) are higher than last year (2.4%).


Past Earnings Growth Analysis

Earnings Trend: 1612's earnings have grown significantly by 30.8% per year over the past 5 years.

Accelerating Growth: 1612's earnings growth over the past year (1714.1%) exceeds its 5-year average (30.8% per year).

Earnings vs Industry: 1612 earnings growth over the past year (1714.1%) exceeded the Medical Equipment industry 19.7%.


Return on Equity

High ROE: 1612's Return on Equity (40.9%) is considered outstanding.


Financial Health

How is Vincent Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1612's short term assets (HK$724.4M) exceed its short term liabilities (HK$330.9M).

Long Term Liabilities: 1612's short term assets (HK$724.4M) exceed its long term liabilities (HK$10.7M).


Debt to Equity History and Analysis

Debt Level: 1612's debt to equity ratio (11.4%) is considered satisfactory.

Reducing Debt: 1612's debt to equity ratio has increased from 2.2% to 11.4% over the past 5 years.

Debt Coverage: 1612's debt is well covered by operating cash flow (113.8%).

Interest Coverage: 1612's interest payments on its debt are well covered by EBIT (97x coverage).


Balance Sheet


Dividend

What is Vincent Medical Holdings's current dividend yield, its reliability and sustainability?

6.67%

Current Dividend Yield


Upcoming Dividend Payment

TodayApr 14 2021Ex Dividend DateMay 24 2021Dividend Pay DateJun 18 202125 days from Ex DividendBuy in the next 39 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 1612's dividend (6.83%) is higher than the bottom 25% of dividend payers in the Hong Kong market (1.96%).

High Dividend: 1612's dividend (6.83%) is in the top 25% of dividend payers in the Hong Kong market (6.02%)


Stability and Growth of Payments

Stable Dividend: 1612 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 1612's dividend payments have increased, but the company has only paid a dividend for 4 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (32.5%), 1612's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 1612's dividends in 3 years are forecast to be well covered by earnings (30.3% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average board tenure


CEO

Ki Cheung To (53 yo)

no data

Tenure

HK$1,776,000

Compensation

Mr. Ki Cheung To serves as Chief Executive Officer and General Manager at Vincent Medical Holdings Limited and has been its Executive Director November 2015. Mr. To is primarily responsible for overseeing ...


CEO Compensation Analysis

Compensation vs Market: Ki Cheung's total compensation ($USD228.47K) is about average for companies of similar size in the Hong Kong market ($USD232.75K).

Compensation vs Earnings: Ki Cheung's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: 1612's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2%.


Top Shareholders

Company Information

Vincent Medical Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Vincent Medical Holdings Limited
  • Ticker: 1612
  • Exchange: SEHK
  • Founded: 1997
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$1.047b
  • Shares outstanding: 650.60m
  • Website: https://www.vincentmedical.com

Number of Employees


Location

  • Vincent Medical Holdings Limited
  • Hang Fung Industrial Building
  • Flat B2, 7th Floor, Phase 2
  • Hung Hom
  • Kowloon
  • Hong Kong

Listings


Biography

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/14 10:28
End of Day Share Price2021/04/14 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.